
BeiGene stock rises on FDA fast track tag for investigational cancer therapy (NASDAQ:BGNE)
JHVEPhoto BeiGene (NASDAQ:BGNE) has obtained FDA Fast Track Designation for its investigational cancer therapy. BGB-16673, an orally obtainable BTK-targeting chimeric degradation activation compound,…


